← Evidence map

ReviewOncogene2007

Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphoma.

T A WaldmannPubMed ↗Publisher ↗

No numbers read from the abstract.

30 papers cite it

2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 17530023